Identification of Monosialylated N -glycoforms in the CDG Urinome by Ion Mobility Tandem Mass Spectrometry: The Potential for Clinical Applications

Clinical Proteomics

Iain Campuzano²  James Langridge²  Jasna Peter-Katalinić¹  Chris Hughes²  Sergey Y. Vakhrushev¹ 

[1] Institute for Medical Physics and Biophysics, Biomedical Analysis Department, University of Münster, Muenster, GermanyInstitute for Medical Physics and Biophysics, Biomedical Analysis Department, University of Münster, Muenster, GermanyInstitute for Medical Physics and Biophysics, Biomedical Analysis Department, University of Münster, Muenster, Germany;Waters Corporation, Manchester, UKWaters Corporation, Manchester, UKWaters Corporation, Manchester, UK

关键词: Glycomics;    Glycoconjugates;    IMS MS;    Congenital disorders of glycosylation;   

DOI  :  10.1007/s12014-008-9010-3

来源: Humana Press Inc

【 摘 要 】

Abstract

Introduction

A novel approach of ion mobility tandem mass spectrometry (IMS-MS/MS) is applied to analysis of human glycourinome to obtain carbohydrate pattern data of congenital disorders of glycosylation patient. Overlapping of the complex carbohydrate mass range landscape has been highly reduced upon IMS-MS procedure, allowing more efficient identification by mapping and sequencing of glycan precursor ions, following their separation by mobility, according to difference in drift time through the traveling wave IMS cell. Intact and truncated N- and O-glycan structures modified by sialylation and fucosylation were identified according to their drift time separated molecular ions and submitted to fragmentation in a narrow mass window.

IMS CID MS/MS Analysis

The fragmentation spectra generated from the IMS separated precursor ions contain series of fragment ions maintaining the same mobility as their parent ions, and the assignment accuracy can be significantly enhanced.

Conclusion

According to the specific fragment ion patterns, carbohydrate epitopes described to be involved in pathological processes were assigned. A high potential of this glycomics-based strategy for clinical applications can be presented.

【 授权许可】

Unknown